Progyny (PGNY) Misses Q4 EPS by 1c, Revenues Miss; Offers Q1 & FY20 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Progyny, Inc. Announces Fourth Quarter and Full Year 2019 Results
March 5, 2020 4:06 PM ESTReports 118% Increase in 2019 Revenue to $229.7 Million Issues Revenue Guidance of $395.0 to $415.0 Million for 2020, Reflecting Growth of 72% to 81%Issues Revenue Guidance of $89.0 to $94.0 Million for the First Quarter of 2020
NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three- and twelve-month periods ended December 31, 2019 (the fourth quarter of 2019 and the full year, respectively) as compared to the three- and twelve-month periods ended December 31, 2018 (the fourth quarter of 2018... More
